Another report by Hu et al. revealed that AS-IV inhibits cell proliferation and metastasis of breast cancer through the promotion of the long noncoding RNA TRHDE‐AS1 where the Low expression of TRHDE-AS1 is linked to poor outcomes in breast cancer patients and plays a role in the aggressive tumor biology of breast cancer (Hu et al. 2021). The gene discussed is TRHDE; the disease is breast carcinoma.